PSQ Holdings, Inc. — Form 8-K Summary
Registrant and period: The filing is by Colombier Acquisition Corp., the predecessor registrant identified in the request as PSQ Holdings, Inc. It reports events occurring July 1–2, 2021, with July 1, 2021 as the earliest reported event.
Business Context
Colombier Acquisition Corp. was a special purpose acquisition company that completed its initial public offering on June 11, 2021. The filing concerns completion of the IPO underwriters’ over-allotment and the planned separation of its publicly traded units into common stock and warrants.
Financial and Capitalization Highlights
- The underwriters exercised their full option to purchase 2,250,000 additional units at $10.00 per unit, generating gross proceeds of $22.5 million.
- The original IPO consisted of 15,000,000 units and generated gross proceeds of $150.0 million.
- The sponsor previously purchased 5,250,000 private placement warrants for $5.25 million.
- The filing states that $172.5 million of net proceeds from the units, over-allotment units, and private placement warrants was placed in a U.S.-based trust account for public stockholders.
- Each unit consists of one share of Class A common stock and one-third of a warrant. Each whole warrant entitles its holder to purchase one share of Class A common stock at $11.50 per share, subject to adjustment.
- The filing does not provide operating revenue, profit, cash flow, margin, debt, or liquidity metrics beyond the trust-account proceeds.
Material Changes Versus the Prior Comparable Disclosure
- The July 1 over-allotment exercise increased gross IPO proceeds by $22.5 million and added 2,250,000 units.
- The previously filed audited balance sheet as of June 11, 2021 did not reflect the over-allotment proceeds. A pro forma balance sheet reflecting those proceeds was filed as Exhibit 99.1.
- Beginning July 6, 2021, holders could separately trade the Class A common stock and warrants. Units not separated would continue trading as CLBR.U; separated shares and warrants would trade as CLBR and CLBR WS, respectively, on the New York Stock Exchange.
Guidance, Outlook, Risks, and Unusual Items
No financial guidance or operating outlook is provided. The principal disclosed event is the completion of the over-allotment financing and placement of proceeds in the trust account. The filing does not describe debt, contingencies, litigation, or other unusual items. The warrant exercise price is subject to adjustment under the company’s registration statement.
Investor Verification Items
- Verify the pro forma balance sheet and the composition of the stated $172.5 million trust-account amount.
- Confirm the terms and any adjustment provisions applicable to the public and private placement warrants.
- Review the company’s subsequent filings for the proposed business combination, use of trust funds, redemption rights, and any changes to the registrant name or capital structure.
- Confirm the effective trading dates and symbols for the separated common stock and warrants.